chr12-130407728-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001393629.1(RIMBP2):c.3691G>A(p.Glu1231Lys) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00154 in 1,612,764 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001393629.1 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RIMBP2 | NM_001393629.1 | c.3691G>A | p.Glu1231Lys | missense_variant, splice_region_variant | 20/23 | ENST00000690449.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RIMBP2 | ENST00000690449.1 | c.3691G>A | p.Glu1231Lys | missense_variant, splice_region_variant | 20/23 | NM_001393629.1 | P5 |
Frequencies
GnomAD3 genomes AF: 0.00130 AC: 197AN: 152004Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00122 AC: 307AN: 251452Hom.: 2 AF XY: 0.00130 AC XY: 177AN XY: 135890
GnomAD4 exome AF: 0.00157 AC: 2286AN: 1460642Hom.: 7 Cov.: 31 AF XY: 0.00162 AC XY: 1177AN XY: 726706
GnomAD4 genome AF: 0.00130 AC: 197AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.00116 AC XY: 86AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 15, 2021 | The c.2923G>A (p.E975K) alteration is located in exon 16 (coding exon 14) of the RIMBP2 gene. This alteration results from a G to A substitution at nucleotide position 2923, causing the glutamic acid (E) at amino acid position 975 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at